5-Methylcytosine (m5C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis

Overview of attention for article published in Frontiers in immunology, September 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 53,420 followers.

5-Methylcytosine (m5C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis: Current non-invasive tumor biomarkers failed to accurately identify patients with colorectal… #immunology https://t.co/

22 Sep 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: 5-Methylcytosine (m5C) modification in peripheral blood immune cells is a novel non-invasive biomarker for…

22 Sep 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: 5-Methylcytosine (m5C) modification in peripheral blood immune cells is a novel non-invasive biomarker for…

22 Sep 2022

Reply Repost Favourite

New Research: 5-Methylcytosine (m5C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis: Current non-invasive tumor biomarkers failed to accurately identify patients with colorectal… https://t.co

21 Sep 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.